Clinical Benefit of Evolocumab by Severity and Extent of Coronary Artery Disease: Analysis From FOURIER

Sabatine, MS; De Ferrari, GM; Giugliano, RP; Huber, K; Lewis, BS; Ferreira, J; Kuder, JF; Murphy, SA; Wiviott, SD; Kurtz, CE; Honarpour, N; Keech, AC; Sever, PS; Pedersen, TR

Sabatine, MS (reprint author), Brigham & Womens Hosp, Div Cardiovasc Med, TIMI Study Grp, Hale Bldg Transformat Med,60 Fenwood Rd,7th Fl, Boston, MA 02115 USA.

CIRCULATION, 2018; 138 (8): 756

Abstract

Background: The FOURIER trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Patients With Elevated Risk) recently showed that the......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索